Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC

Pi-Hung Tung, Tzu-Hsuan Chiu, Allen Chung-Cheng Huang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2016-02

Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation

Elaine Lai-Han Leung, Xing-Xing Fan, Maria Pik Wong [...]

Antioxidants & Redox Signaling

Retricted access

Case report

First published 2022-1

Re-use of erlotinib in a patient using osimertinib after erlotinib,case report

Pinar Gursoy

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2018-5

Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis

Jiguang Jia, Bin Huang, Zhengling Zhuang [...]

The International Journal of Biological Markers

Open access

Research article

First published 2021

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients

Klaus Hackner, Anna Buder, Maximilian J Hochmair [...]

Clinical Medicine Insights: Oncology

Retricted access

Case report

First published 2018-12

Meeting with triumph and disaster: Osimertinib in T790M-unknown CNS progression in EGFR -mutated non-small cell lung cancer

Francesco Facchinetti, Francesca Bozzetti, Roberta Minari [...]

Tumori Journal

Retricted access

Research article

First published 2019-3

Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis

Ruofan Huang, Mengxi Ge, Xinli Zhou [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Review article

First published 2016-12

Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experience

Ivana Sullivan, David Planchard

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2023

Survival Analysis of 159 Patients With Advanced Non-Small-Cell Lung Cancer Resistant to First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

Aimin Hu, Kun Li, Hua Zheng [...]

Clinical Medicine Insights: Oncology

Open access

Review article

First published 2024

Expert consensus on the use of third-generation EGFR-TKIs in EGFR-mutated advanced non-small cell lung cancer with various T790M mutations post-resistance to first-/second-generation EGFR-TKIs

Jietao Ma, Letian Huang, Chengbo Han

Therapeutic Advances in Medical Oncology

Search results